The Booth Gardner Parkinson’s Care Center is conducting a randomized, double-blinded study for patients with Parkinson’s Disease (PD) who have the wearing-off phenomenon on oral levodopa therapy. The purpose of this study is to see if the Earstim device can improve PD motor function symptoms. The researchers will study the safety related to use of the device, and if any improvement in symptoms continues after the therapy has stopped.
Who may be eligible to participate?
Male or female patients, age 18 and older, who have Parkinson’s Disease and are on levodopa therapy. Participants must have daily “OFF” time duration of ≥2 hours per day. Other inclusion/exclusion criteria apply.
What does participation involve?
All participants will receive three treatments on different days, each with different stimulation conditions. All subjects will wear the Earstim device on the ear on the side of the body more affected by Parkinson’s Disease for 120 minutes during each of the three treatment applications. Each subject will participate in the study for approximately 1 month.
Pinky Agarwal, M.D., FAAN